Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor-Treating Fields (TTFields) in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma: A Safety and Efficacy Clinical Study

NCT06353360 is registered in ClinicalTrials.gov with Jiangsu Healthy Life Innovation Medical Technology Co., Ltd as lead sponsor.

NCT NCT06353360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06353360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor-Treating Fields (TTFields) in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma: A Safety and Efficacy Clinical Study
Lead sponsor
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2024
Completion date
March 9, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme